This website uses functional cookies, including analytical cookies.
The obtained statistical data cannot be traced back to individual users.
Additionally, you can choose to accept or refuse consent to use marketing cookies.
If you decline these additional cookies or refrain from making a choice, only functional cookies will be set.
See our cookie policy for more information.
Xencor Appoints Bart Cornelissen as Chief Financial Officer
Xencor Appoints Bart Cornelissen as Chief Financial Officer
Xencor, a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen to senior vice president and chief financial officer. Cornelissen is an alumnus of RSM's MScBA.